← FDA DRUG APPROVALS

FDA ANDA · ANDA070577

VERAPAMIL HYDROCHLORIDE

Sponsor: HOSPIRA

APPLICATION
ANDA070577
TYPE
ANDA
ORIGINAL APPROVAL
1987-02-02
LATEST ACTION
2001-02-14
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

VERAPAMIL HYDROCHLORIDEDiscontinued
VERAPAMIL HYDROCHLORIDE 2.5MG/ML · INJECTABLE · INJECTION

Approval history

2001-02-14Manufacturing (CMC) · Supplement 11AP
1996-03-04Labeling · Supplement 9AP
1995-12-22Manufacturing (CMC) · Supplement 10AP
1992-04-28Manufacturing (CMC) · Supplement 3AP
1992-04-28Manufacturing (CMC) · Supplement 4AP
1991-03-21Labeling · Supplement 7AP
1990-11-01Labeling · Supplement 6AP
1990-03-29Labeling · Supplement 5AP
1987-02-02OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →